Early Optical Tomography Changes Predict Breast Cancer Response to Neoadjuvant Chemotherapy

被引：0
|
作者：
Lim, E. A.
Gunther, J. E.
Flexman, M.
Kim, H. K.
Hibshoosh, H.
Kalinsky, K.
Crew, K.
Maurer, M.
Taback, B.
Feldman, S.
Brown, M.
Refice, S.
Alvarez-Cid, M.
Hielscher, A.
Hershman, D. L.
机构：
[1] Columbia Univ, Med Ctr, New York, NY 10027 USA
[2] Columbia Univ, New York, NY USA
[3] Herbert Irving Comprehens Canc Ctr, New York, NY USA
[4] Mailman Sch Publ Hlth, New York, NY USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS12-P4-02-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-02-07
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Diffuse optical tomography of the breast: a potential modifiable biomarker of breast cancer risk with neoadjuvant chemotherapy
    Altoe, Mirella L.
    Marone, Alessandro
    Kim, Hyun K.
    Kalinsky, Kevin
    Hershman, Dawn L.
    Hielscher, Andreas H.
    Ha, Richard S.
    BIOMEDICAL OPTICS EXPRESS, 2019, 10 (08) : 4305 - 4315
  • [32] Predicting Treatment Response of Breast Cancer to Neoadjuvant Chemotherapy Using Ultrasound-Guided Diffuse Optical Tomography
    Zhi, Wenxiang
    Liu, Guangyu
    Chang, Cai
    Miao, Aiyu
    Zhu, Xiaoli
    Xie, Li
    Zhou, Jin
    TRANSLATIONAL ONCOLOGY, 2018, 11 (01): : 56 - 64
  • [33] Diffuse optical tomography can predict pathologic complete response in patients with HER2+or triple negative breast cancer undergoing neoadjuvant chemotherapy
    Kalinsky, K.
    Lee, S.
    Zhong, X.
    Lim, E. A.
    Gunther, J. E.
    Hibshoosh, H.
    Kim, H. K.
    Accordino, M.
    Crew, K.
    Hielscher, A.
    Hershman, D. L.
    CANCER RESEARCH, 2017, 77
  • [34] Dedicated breast PET to predict pathological complete response after neoadjuvant chemotherapy for breast cancer
    Fujiwara, M.
    Masumoto, N.
    Sasada, S.
    Kadoya, T.
    Okada, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [35] Do Tumor Characteristics Predict Changes in Breast Cancer Biomarkers Following Neoadjuvant Chemotherapy?
    Xian, Zhaoying
    Quinones, Alexander K.
    Tozbikian, Gary
    Zynger, Debra L.
    LABORATORY INVESTIGATION, 2017, 97 : 79A - 79A
  • [36] Do Tumor Characteristics Predict Changes in Breast Cancer Biomarkers Following Neoadjuvant Chemotherapy?
    Xian, Zhaoying
    Quinones, Alexander K.
    Tozbikian, Gary
    Zynger, Debra L.
    MODERN PATHOLOGY, 2017, 30 : 79A - 79A
  • [37] Neoadjuvant or adjuvant chemotherapy in early breast cancer?
    Montemurro, Filippo
    Nuzzolese, Imperia
    Ponzone, Riccardo
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (09) : 1071 - 1082
  • [38] Neoadjuvant chemotherapy for early breast cancer Reply
    McGale, Paul
    Dodwell, David
    Taylor, Carolyn
    Gray, Richard
    LANCET ONCOLOGY, 2018, 19 (03): : E130 - E130
  • [39] Early progression of breast cancer during neoadjuvant chemotherapy may predict poorer prognoses
    Myller, Sylvia
    Ipatti, Pieta
    Jaaskelainen, Anniina
    Haapasaari, Kirsi-Maria
    Jukkola, Arja
    Karihtala, Peeter
    ACTA ONCOLOGICA, 2020, 59 (09) : 1036 - 1042
  • [40] Tumor-Associated Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
    Lee, Hee Jin
    Seo, Jin-Young
    Ahn, Jin-Hee
    Ahn, Sei-Hyun
    Gong, Gyungyub
    JOURNAL OF BREAST CANCER, 2013, 16 (01) : 32 - 39
12345